When it comes to the potential of H5N1 avian flu picking up mutations that might lead to human-to-human spread, that "train has already left the station," warns 1 infectious disease expert.
Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.
Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for decolonization interventions.